Featured Research

Novel drug treatment protects primates from deadly Marburg virus

Date:

March 4, 2014

Source:

US Army Medical Research Institute of Infectious Diseases

Summary:

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

Share This

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

Related Articles

According to senior author Sina Bavari, the drug, known as BCX4430, protected cynomolgous macaques from Marburg virus infection when administered by injection as long as 48 hours post-infection. Bavari and his team at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) also found that BCX4430 protected guinea pigs exposed to Marburg virus by the inhalation route.

Developed by BioCryst Pharmaceuticals, Inc., BCX4430 also demonstrated activity against a broad range of other RNA viruses, including the emerging viral pathogen Middle East respiratory syndrome coronavirus (MERS-CoV), when tested in cell culture.

"This study demonstrates the importance of government-industry collaboration," said COL Erin P. Edgar, commander of USAMRIID. "Developing filovirus medical countermeasures is a top biodefense priority for the United States. When federal assets like USAMRIID team up with cutting-edge partners in private industry, we can make real progress toward achieving that goal."

The paper's first author, Travis K. Warren of USAMRIID, said findings from the work show the drug acts by interfering with the internal "machinery" of the Marburg virus, preventing it from replicating its genetic material. He said the team is currently planning additional studies to determine whether the therapeutic window can be extended beyond 48 hours. In addition, BioCryst plans to file investigational new drug (IND) applications for intravenous and intramuscular BCX4430 for the treatment of Marburg virus disease, and to conduct Phase 1 human clinical trials, according to Warren.

Ebola and Marburg cause hemorrhagic fever with case fatality rates as high as 90 percent in humans. The viruses, which are infectious by aerosol (although more commonly spread through blood and bodily fluids of infected patients), are of concern both as global health threats and as potential agents of biological warfare or terrorism. Currently there are no available vaccines or therapies. Research on both viruses is conducted in Biosafety Level 4, or maximum containment, laboratories, where investigators wear positive-pressure "space suits" and breathe filtered air as they work.

More From ScienceDaily

More Plants & Animals News

Featured Research

Mar. 3, 2015 — By examining the forces that the segments of mosquito legs generate against a water surface, researchers have unraveled the mechanical logic that allows the mosquitoes to walk on water, which may ... full story

Mar. 3, 2015 — Researchers have developed a new way of rapidly screening yeasts that could help produce more sustainable biofuels. The new technique could also be a boon in the search for new ways of deriving ... full story

Mar. 3, 2015 — Similar to humans and animals, plants possess an innate immune system that protects them from invading pathogens. Molecular structures that only occur in pathogens enable their recognition and ... full story

Mar. 3, 2015 — For almost a century, scientists have been puzzled by a process that is crucial to much of the life in Earth's oceans: Why does calcium carbonate, the tough material of seashells and corals, ... full story

Mar. 3, 2015 — To simulate chimp behavior, scientists created a computer model based on equations normally used to describe the movement of atoms and molecules in a confined space. An interdisciplinary research ... full story

Mar. 3, 2015 — Rather than just waiting patiently for any pollinator that comes their way to start the next generation of seeds, some plants appear to recognize the best suitors and 'turn on' to increase the chance ... full story

Mar. 3, 2015 — Two of the four known groups of human AIDS viruses (HIV-1 groups O and P) have originated in western lowland gorillas, according to new research. The scientists conducted a comprehensive survey of ... full story

Mar. 3, 2015 — Methane emissions are strongly reduced in lakes with anoxic bottom waters. But – contrary to what has previously been assumed – methane removal is not always due to archaea or anaerobic bacteria. ... full story

Featured Videos

Rare Goblin Shark Found in Australia

AFP (Mar. 3, 2015) — A goblin shark, a rare sea creature described as an &apos;alien of the deep&apos; is found off Australia and delivered to the Australian Museum in Sydney. Duration: 01:25
Video provided by AFP

Zookeepers Copy Animal Poses In Hilarious Viral Photos

Buzz60 (Mar. 2, 2015) — Zookeepers at the Symbio Wildlife Park in Helensburgh, Australia decided to take some of their favorite animal photos and recreate them by posing just like the animals. Jen Markham (@jenmarkham) has the story.
Video provided by Buzz60

Related Stories

Aug. 20, 2014 — For the first time, researchers have protected nonhuman primates against Marburg virus -- Angola hemorrhagic fever. Their treatment was shown to be effective at a point when animals have detectable ... full story

Mar. 13, 2014 — With approximately a 90% death rate and no treatment yet available, Marburg virus research and development are a top priority. Once restricted to Africa, cases of the virus have been identified in ... full story

Jan. 14, 2013 — Researchers have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and ... full story

Aug. 24, 2011 — Researchers have identified a cellular protein that is critical for infection by the deadly Ebola virus. The findings suggest a possible strategy for blocking infection due to Ebola virus, one of the ... full story

June 16, 2010 — An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.